tiprankstipranks
Trending News
More News >
Arjo AB Class B (ARRJF)
OTHER OTC:ARRJF

Arjo AB (ARRJF) Price & Analysis

Compare
3 Followers

ARRJF Stock Chart & Stats

$3.46
-$0.40(-11.64%)
At close: 4:00 PM EST
$3.46
-$0.40(-11.64%)

Arjo AB News

ARRJF FAQ

What was Arjo AB Class B’s price range in the past 12 months?
Arjo AB Class B lowest stock price was $2.84 and its highest was $4.02 in the past 12 months.
    What is Arjo AB Class B’s market cap?
    Arjo AB Class B’s market cap is $937.45M.
      When is Arjo AB Class B’s upcoming earnings report date?
      Arjo AB Class B’s upcoming earnings report date is Jan 30, 2026 which is in 32 days.
        How were Arjo AB Class B’s earnings last quarter?
        Arjo AB Class B released its earnings results on Oct 22, 2025. The company reported $0.036 earnings per share for the quarter, missing the consensus estimate of $0.038 by -$0.002.
          Is Arjo AB Class B overvalued?
          According to Wall Street analysts Arjo AB Class B’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Arjo AB Class B pay dividends?
            Arjo AB Class B pays a Annually dividend of $0.1 which represents an annual dividend yield of 3.11%. See more information on Arjo AB Class B dividends here
              What is Arjo AB Class B’s EPS estimate?
              Arjo AB Class B’s EPS estimate is 0.08.
                How many shares outstanding does Arjo AB Class B have?
                Arjo AB Class B has 254,152,370 shares outstanding.
                  What happened to Arjo AB Class B’s price movement after its last earnings report?
                  Arjo AB Class B reported an EPS of $0.036 in its last earnings report, missing expectations of $0.038. Following the earnings report the stock price went down -3.293%.
                    Which hedge fund is a major shareholder of Arjo AB Class B?
                    Currently, no hedge funds are holding shares in ARRJF
                    What is the TipRanks Smart Score and how is it calculated?
                    Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                      Company Description

                      Arjo AB Class B

                      Arjo AB (publ) develops and sells medical devices and solutions for patients with reduced mobility and age-related health challenges in North America, Western Europe, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, treatment and prevention of pressure injuries and leg ulcers, prevention of deep vein thrombosis, treatment of edema, and for obstetric and cardiac diagnostics. The company also provides dementia and bariatric room assessment solutions, as well as clinical consulting, maintenance, and equipment rental and financing solutions. It serves private and public institutions that provide acute and long-term care. The company was founded in 1957 and is headquartered in Malmö, Sweden.

                      Arjo AB (ARRJF) Earnings & Revenues

                      ARRJF Company Deck

                      ARRJF Earnings Call

                      Q3 2025
                      0:00 / 0:00
                      Earnings Call Sentiment|Neutral
                      The earnings call reflected a challenging quarter with lower-than-expected organic growth primarily due to weak capital sales in Europe and Asia. Despite these challenges, the company showed resilience with improvements in gross margin, strong operational cash flow, and strategic executive appointments. However, the significant negative impact of currency effects and the decline in adjusted EBIT and EBITDA suggest ongoing challenges.View all ARRJF earnings summaries
                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      Elekta AB
                      Vitrolife AB
                      AddLife AB
                      BONESUPPORT HOLDING AB
                      MedCap AB

                      Ownership Overview

                      5.28%88.72%
                      Insiders
                      ― Other Institutional Investors
                      88.72% Public Companies and
                      Individual Investors

                      Options Prices

                      Currently, No data available
                      ---
                      Popular Stocks